PAPP-A: a possible pathogenic link to the instability of atherosclerotic plaque

Xuping Li1, Qiming Liu, Tao Zhou

  • 1Department of Cardiology, Second Xiangya Hospital, Central South University, Renming Road 359, Changsha, China.

Medical Hypotheses
|August 24, 2007
PubMed

Insights

Pregnancy associated plasma protein A (PAPP-A) may cause atherosclerotic plaque instability, a key factor in acute coronary syndromes (ACS). Targeting PAPP-A could offer a new treatment strategy for ACS patients.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Pathology

Background:

  • Acute coronary syndromes (ACS) are primarily caused by the rupture of coronary atherosclerotic plaques and subsequent thrombus formation.
  • Elevated serum concentrations of Pregnancy associated plasma protein A (PAPP-A) are linked to ACS, indicating plaque instability and poor prognosis.
  • The high expression of PAPP-A in unstable plaques remains a puzzling observation.

Purpose of the Study:

  • To investigate the hypothesis that PAPP-A contributes to atherosclerotic plaque instability, playing a role in ACS pathogenesis.
  • To explore PAPP-A as a potential therapeutic target for ACS.

Main Methods:

  • Review of existing studies examining PAPP-A expression in different types of atherosclerotic plaques (eroded, ruptured, stable).
  • Analysis of PAPP-A levels in patients with varying carotid plaque echogenicity (hyperechoic, isoechoic, hypoechoic).

Main Results:

  • PAPP-A is abundantly expressed in eroded and ruptured plaques, but minimally in stable plaques.
  • Higher PAPP-A levels are observed in patients with hyperechoic or isoechoic carotid plaques compared to those with hypoechoic lesions.

Conclusions:

  • PAPP-A expression correlates with atherosclerotic plaque instability.
  • PAPP-A may be a causative factor in plaque instability and ACS.
  • PAPP-A monoclonal antibodies represent a potential novel therapeutic approach for treating ACS.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...